SCHEMBL7097807

SCHEMBL7097807

COc1cccc(C(=O)C2CCN(C(=O)O)CC2)c1F

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 6/20 0.57
LMNA P02545 3/20 0.57
KMT2A Q03164 2/20 0.57
HTR2A P28223 2/20 0.51
GRM2 Q14416 2/20 0.51
MGLL Q99685 1/20 0.50
HSD17B10 Q99714 1/20 0.48
ALDH1A1 P00352 3/20 0.47
HTT P42858 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
CPS1 P31327 1/20 0.47
HTR1F P30939 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14637537 0.87 KMT2A (0.62) HSD11B1LMNAKMT2AMGLLHSD17B10
SCHEMBL4232496 0.86 HSD11B1 (0.64) HSD11B1LMNAKMT2AHTR2AGRM2
SCHEMBL7094262 0.85 HSD11B1 (0.47) HSD11B1LMNAKMT2AHTR2AGRM2
SCHEMBL2956024 0.84 HSD11B1 (0.52) HSD11B1LMNAKMT2AHTR2AGRM2
SCHEMBL17938078 0.76 HSD11B1 (0.60) HSD11B1KMT2AMGLLHTTCPS1
SCHEMBL16446727 0.74 ALDH1A1 (0.56) HSD11B1LMNAKMT2AHSD17B10ALDH1A1
SCHEMBL10954882 0.74 KAT6A (0.52) LMNAKMT2AHSD17B10ALDH1A1HTT
SCHEMBL13220728 0.73 STS (0.48) HSD11B1LMNAKMT2AALDH1A1
SCHEMBL13701329 0.72 HTR2A (0.57) HSD11B1LMNAKMT2AHTR2AGRM2
SCHEMBL13701275 0.72 HTR2A (0.71) HSD11B1LMNAKMT2AHTR2AGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1361875-A2 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS Aventis Pharmaceuticals Inc. (US) 2003-11-19 EP disclosed
WO-2002066469-A2 NOVEL HETEROCYCLIC AMIDE DERIVATIVES AND THEIR USE AS DOPAMINE D3 RECEPTOR LIGANDS AVENTIS PHARMACEUTICALS INC. (US) 2002-08-29 WO disclosed